Spegra™ is a licensed generic of Tivicay® + Descovy® produced in an FDA-approved manufacturing facility in India. It’s a fixed-dose combination antiretroviral complete regimen treatment for HIV-1.
- Tivicay® + Descovy® may help decrease the amount of HIV in your body so that your immune system can work better
- It may lower your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life
- It’s indicated in adult and pediatric patients weighing at least 88 pounds (40 kg)